BlueWind Medical, a medical device company developing minimally invasive neurostimulation devices, has appointed Kerry Nelson to the company’s Board of Directors. She will provide strategic, financial and operational counsel to the company as it advances its technology and looks toward commercialization. Kerry is Portfolio Manager and Founder of Skystone Capital Management LP, which has been solely focused on the healthcare industry since a spin out from JP Morgan Chase & Co. She joins Directors Ilan Neugarten and Yossi Gross, both of Rainbow Medical, and Chairman and CEO Dan Lemaitre, on the board.
BlueWind Medical, a medical device company developing minimally invasive neurostimulation devices, has appointed Kerry Nelson to the company’s Board of Directors. She will provide strategic, financial and operational counsel to the company as it advances its technology and looks toward commercialization. Kerry is Portfolio Manager and Founder of Skystone Capital Management LP, which has been solely focused on the healthcare industry since a spin out from JP Morgan Chase & Co. She joins Directors Ilan Neugarten and Yossi Gross, both of Rainbow Medical, and Chairman and CEO Dan Lemaitre, on the board.